Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Paxman AB (publ)
  6. News
  7. Summary
    PAX   SE0009806284

PAXMAN AB (PUBL)

(PAX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Paxman : signs new distribution agreements with partners in Indonesia and Bangladesh

06/18/2021 | 03:01am EDT

Paxman today announce PT. Gekha Karunia Abadi as their exclusive distribution partner for the new territory of Indonesia, and VisionTech International as their global distribution partner for Paxman equipment in Bangladesh.

A long established medical device distributor in the oncology space, PT. Gekha Karunia Abadi are well positioned to introduce scalp cooling to the Indonesian market from their headquarters in the capital city of Jakarta.

With a population of over 270 million, Indonesia is the fourth most populous country in the world and non-communicable diseases, such as cancer, dominate the mortality rate - with cancer showing a rising trend.

The government implemented health insurance system covers more than 80% of the Indonesian population and in the near future, it hopes to reach the entire population. It is currently one of the largest single-payer systems in the world, which has provided hundreds of millions of Indonesians with access to health insurance. This is key to easing the country’s cancer burden by ensuring early screening and diagnosis. This goal is also being aided by the National Cancer Control Program, which aims to increase public awareness and knowledge for the prevention, early detection, and treatment of cancer in the country along with the adoption of a nationwide cancer registry. The country has 2,000 hospitals, half privately owned and half publicly owned however, healthcare disparities in cancer care are still a major issue in the region.

Headquartered in the capital of Dhaka, the largest city in the country, VisionTech International are a trusted importer and supplier of world-leading medical equipment and devices to hospitals across the country, having significant experience in the sector. Their committed approach to their established customer base in Bangladesh, along with their solid reputation will play an important part of the effective launch of Paxman Scalp Cooling in the region.

The People's Republic of Bangladesh is one of the most densely populated countries in the world, with a population of over 164 million. Around 67 per cent of deaths in Bangladesh are caused by non-communicable disease such as cancer and breast cancer is one of the most common cases of cancer accounting for 8.5% of the total incidences.

There are a total of 22 privately operated cancer centres throughout the country with a further 15 government run cancer care institutions – the most important of these being the National Institute of Cancer Research & Hospital (NICRH) located in Dhaka.

© Modular Finance, source Nordic Press Releases

All news about PAXMAN AB (PUBL)
06/29PAXMAN : publishes newsletter on new distribution partners in Indonesia and Bang..
AQ
06/18PAXMAN : signs new distribution agreements with partners in Indonesia and Bangla..
AQ
06/16PAXMAN : RedEye publishes analysis of Paxman
AQ
05/28PAXMAN : publishes newsletter on research grant to the company's development of ..
AQ
05/26PAXMAN : Press release from PAXMAN AB's 2021 Annual General Meeting
AQ
05/26PAXMAN : publishes its interim report for Q1 2021
AQ
05/26Paxman AB Publ Reports Earnings Results for the First Quarter Ended March 31,..
CI
05/21PAXMAN : Announces singapore-uk team to develop a novel device to reduce chemoth..
AQ
05/21Paxman Partners Paxman Coolers Ltd to Develop a Device
CI
05/11PAXMAN : View CEO Richard Paxman's participation in Redeye's virtual Medtech Dia..
AQ
More news
Financials
Sales 2020
Net income 2020
Net Debt 2020
P/E ratio 2020
Yield 2020
Capitalization 923 M 107 M 107 M
EV / Sales 2020
EV / Sales 2021 10,0x
Nbr of Employees 51
Free-Float 28,9%
Chart PAXMAN AB (PUBL)
Duration : Period :
Paxman AB (publ) Technical Analysis Chart | PAX | SE0009806284 | MarketScreener
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 1
Last Close Price 52,40 SEK
Average target price 90,00 SEK
Spread / Average Target 71,8%
Managers and Directors
Richard Paxman Chief Executive Officer & Director
Per-Anders Karl Johansson Chairman
Patrick Burke Manager-Technical & Engineering
Alexandra Sheldrake Head-Regulatory Affairs & Operations
Bj÷rn Littorin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PAXMAN AB (PUBL)106.30%107
ABBOTT LABORATORIES10.44%214 853
MEDTRONIC PLC12.05%176 401
BECTON, DICKINSON AND COMPANY2.22%74 487
ALIGN TECHNOLOGY, INC.31.24%55 396
HOYA CORPORATION15.03%54 156